Matches in Wikidata for { <http://www.wikidata.org/entity/Q38892845> ?p ?o ?g. }
- Q38892845 description "2016 nî lūn-bûn" @default.
- Q38892845 description "2016年の論文" @default.
- Q38892845 description "2016年学术文章" @default.
- Q38892845 description "2016年学术文章" @default.
- Q38892845 description "2016年学术文章" @default.
- Q38892845 description "2016年学术文章" @default.
- Q38892845 description "2016年学术文章" @default.
- Q38892845 description "2016年學術文章" @default.
- Q38892845 description "2016年學術文章" @default.
- Q38892845 description "2016年學術文章" @default.
- Q38892845 description "2016年學術文章" @default.
- Q38892845 description "2016年學術文章" @default.
- Q38892845 description "2016年學術文章" @default.
- Q38892845 description "2016년 논문" @default.
- Q38892845 description "article científic" @default.
- Q38892845 description "article scientific" @default.
- Q38892845 description "article scientifique (publié 2016)" @default.
- Q38892845 description "articol științific" @default.
- Q38892845 description "articolo scientifico" @default.
- Q38892845 description "artigo científico (publicado na 2016)" @default.
- Q38892845 description "artigo científico (publicado na 2016)" @default.
- Q38892845 description "artigo científico" @default.
- Q38892845 description "artikull shkencor" @default.
- Q38892845 description "artikulong pang-agham" @default.
- Q38892845 description "artykuł naukowy" @default.
- Q38892845 description "artículo científico publicado en 2016" @default.
- Q38892845 description "artículu científicu espublizáu en 2016" @default.
- Q38892845 description "bilimsel makale" @default.
- Q38892845 description "bài báo khoa học" @default.
- Q38892845 description "mokslinis straipsnis" @default.
- Q38892845 description "naučni članak" @default.
- Q38892845 description "scienca artikolo" @default.
- Q38892845 description "scientific article" @default.
- Q38892845 description "teaduslik artikkel" @default.
- Q38892845 description "tieteellinen artikkeli" @default.
- Q38892845 description "tudományos cikk" @default.
- Q38892845 description "vedecký článok" @default.
- Q38892845 description "vetenskaplig artikel" @default.
- Q38892845 description "videnskabelig artikel (udgivet 2016)" @default.
- Q38892845 description "vitenskapelig artikkel" @default.
- Q38892845 description "vitskapeleg artikkel" @default.
- Q38892845 description "vědecký článek" @default.
- Q38892845 description "wetenschappelijk artikel" @default.
- Q38892845 description "wissenschaftlicher Artikel" @default.
- Q38892845 description "επιστημονικό άρθρο" @default.
- Q38892845 description "мақолаи илмӣ" @default.
- Q38892845 description "мақолаи илмӣ" @default.
- Q38892845 description "наукова стаття, опублікована в лютому 2016" @default.
- Q38892845 description "научна статия" @default.
- Q38892845 description "научная статья" @default.
- Q38892845 description "научни чланак" @default.
- Q38892845 description "научни чланак" @default.
- Q38892845 description "գիտական հոդված" @default.
- Q38892845 description "מאמר מדעי" @default.
- Q38892845 description "سائنسی مضمون" @default.
- Q38892845 description "مقالة علمية نشرت بتاريخ 27-2-2016" @default.
- Q38892845 description "مقالهٔ علمی" @default.
- Q38892845 description "২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q38892845 description "บทความทางวิทยาศาสตร์" @default.
- Q38892845 description "სამეცნიერო სტატია" @default.
- Q38892845 name "Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)." @default.
- Q38892845 name "Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)." @default.
- Q38892845 name "Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)." @default.
- Q38892845 type Item @default.
- Q38892845 label "Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)." @default.
- Q38892845 label "Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)." @default.
- Q38892845 label "Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)." @default.
- Q38892845 prefLabel "Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)." @default.
- Q38892845 prefLabel "Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)." @default.
- Q38892845 prefLabel "Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)." @default.
- Q38892845 P1433 Q38892845-FCD6C9BB-A65E-4CCB-9871-5CAEC96181C3 @default.
- Q38892845 P1476 Q38892845-BD2DD513-CFA1-4FAE-B49F-28E4FE37DE73 @default.
- Q38892845 P2093 Q38892845-30999F78-85B4-4243-891A-4882984F1D7A @default.
- Q38892845 P2093 Q38892845-5C0CD4F0-BB25-4764-81A8-A1461151D361 @default.
- Q38892845 P2093 Q38892845-7A6509D8-B909-4520-B99C-5EBF1C53CDFA @default.
- Q38892845 P2093 Q38892845-A10181C4-3FB1-44AC-8523-448098327493 @default.
- Q38892845 P2093 Q38892845-E09955D2-71CC-4881-A178-86378312F0EB @default.
- Q38892845 P304 Q38892845-B5B7EFE3-A637-4A8F-B902-553DB1D00517 @default.
- Q38892845 P31 Q38892845-DC742640-484A-4199-BAD1-D53F12B59B9D @default.
- Q38892845 P356 Q38892845-1A1391D1-05DD-4F67-8E13-A884E56E3270 @default.
- Q38892845 P407 Q38892845-6B8C326C-0097-46A5-AEEF-48C9713A645C @default.
- Q38892845 P478 Q38892845-B292347E-75E7-473E-9BDF-1DEAC1145D27 @default.
- Q38892845 P50 Q38892845-6F6AD693-7AC7-4A5A-AB58-3FB106A37B34 @default.
- Q38892845 P577 Q38892845-55C6D0D6-5A34-448D-9EF6-99D8BAFCCFD7 @default.
- Q38892845 P698 Q38892845-6557626D-ACFD-43BA-A130-1F7D2D5D0728 @default.
- Q38892845 P921 Q38892845-198BA897-A779-44D5-B392-DC633E3C85E5 @default.
- Q38892845 P921 Q38892845-D3474C73-74CE-4128-A802-B319C7053758 @default.
- Q38892845 P356 J.LEUKRES.2016.02.012 @default.
- Q38892845 P698 26994850 @default.
- Q38892845 P1433 Q15716445 @default.
- Q38892845 P1476 "Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)." @default.
- Q38892845 P2093 "Hao Jiang" @default.
- Q38892845 P2093 "Hong-Hu Zhu" @default.
- Q38892845 P2093 "Jin-Song Jia" @default.
- Q38892845 P2093 "Qian Jiang" @default.
- Q38892845 P2093 "Ya-Zhen Qin" @default.
- Q38892845 P304 "40-44" @default.
- Q38892845 P31 Q13442814 @default.
- Q38892845 P356 "10.1016/J.LEUKRES.2016.02.012" @default.
- Q38892845 P407 Q1860 @default.